financetom
Business
financetom
/
Business
/
Honeywell's Potential Split to Become Two Companies Would Be 'Welcome' But 'Not Surprising," UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Honeywell's Potential Split to Become Two Companies Would Be 'Welcome' But 'Not Surprising," UBS Says
Jan 14, 2025 10:18 AM

01:06 PM EST, 01/14/2025 (MT Newswires) -- Honeywell International ( HON ) could soon disclose plans to become two companies, with the move that may be announced as soon as early February described as a "welcome but not surprising development" for the industrial conglomerate, UBS analysts said in a Monday research note.

Citing people familiar with the matter, Bloomberg reported Monday that Honeywell ( HON ) has decided to spin off its aerospace unit into a stand-alone company, conceding to calls by activist investor Elliott Investment Management to split the industrial conglomerate into its aerospace and automation component businesses. A Honeywell ( HON ) spokesperson late Monday told MT Newswires the company does not comment on market rumors or speculation.

UBS analysts said the news was consistent with their positive view of Honeywell ( HON ) and likely supports a double-digit increase for its share price on a percentage basis based on a sum-of-the-parts valuation.

Honeywell ( HON ) would also benefit from a simpler business model, they said, with the new companies enjoying an improved focus and the prospect of meaningful growth. The analysts also agreed with Elliott that investors will likely value two companies above the price Honeywell ( HON ) now fetches as a single entity.

UBS currently has a buy rating on Honeywell ( HON ) stock with a $289 price target.

Price: 216.50, Change: -2.60, Percent Change: -1.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly Tempers Fourth-Quarter, Full-Year Revenue Expectations; Shares Decline
Eli Lilly Tempers Fourth-Quarter, Full-Year Revenue Expectations; Shares Decline
Jan 14, 2025
01:07 PM EST, 01/14/2025 (MT Newswires) -- Shares of Eli Lilly ( LLY ) tumbled intraday Tuesday after the drugmaker lowered fourth-quarter and full-year revenue expectations amid slower-than-expected growth in its US incretin division. The company now expects fourth-quarter revenue of about $13.5 billion, down $400 million from its previous outlook's low end. Analysts polled by FactSet expected $13.93 billion....
Honeywell's Potential Split to Become Two Companies Would Be 'Welcome' But 'Not Surprising,
Honeywell's Potential Split to Become Two Companies Would Be 'Welcome' But 'Not Surprising," UBS Says
Jan 14, 2025
01:06 PM EST, 01/14/2025 (MT Newswires) -- Honeywell International ( HON ) could soon disclose plans to become two companies, with the move that may be announced as soon as early February described as a welcome but not surprising development for the industrial conglomerate, UBS analysts said in a Monday research note. Citing people familiar with the matter, Bloomberg reported...
Cymat Technologies Up 39% After Partnering With Major Japanese Trading And Manufacturing Co. In Joint Development Agreement
Cymat Technologies Up 39% After Partnering With Major Japanese Trading And Manufacturing Co. In Joint Development Agreement
Jan 14, 2025
01:09 PM EST, 01/14/2025 (MT Newswires) -- Cymat Technologies ( CYMHF ) on Tuesday entered into a joint development agreement with an established Japanese trading and manufacturing company specializing in automotive, chemicals, plastics, electronics and life science products, pushing the company's shares up 39%. The company said primary purpose of the agreement is to jointly develop innovative automotive solutions for...
Update: Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
Update: Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
Jan 14, 2025
01:05 PM EST, 01/14/2025 (MT Newswires) -- (Updates with CVS Health's ( CVS ) response in the fifth and sixth paragraphs.) UnitedHealth Group's ( UNH ) OptumRx, CVS Health's ( CVS ) Caremark Rx and Cigna's ( CI ) Express Scripts marked up a number of specialty generic drugs at their affiliated pharmacies by hundreds or thousands of percent, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved